Usefulness of OCT during coronary intervention

Similar documents
OCT; Comparative Imaging Results with IVUS, VH and Angioscopy

Assessment of plaque morphology by OCT in patients with ACS

Assessment of vulnerable plaque by OCT

OCT Findings: Lesson from Stable vs Unstable Plaques

Analysis of macrophage accumulation using optical coherence tomography one year after sirolimus, paclitaxel and zotarolimus-eluting stent

Culprit Lesion Remodeling and Long-term (> 5years) Prognosis in Patients with Acute Coronary Syndrome

Added Value of Invasive Coronary Imaging for Plaque Rupture and Erosion

Optical Coherence Tomography for Intracoronary Imaging

PCI for Left Anterior Descending Artery Ostial Stenosis

Can IVUS Define Plaque Features that Impact Patient Care?

Can We Identify Vulnerable Patients & Vulnerable Plaque?

Assessment of Vulnerable Plaque by IVUS and VH-IVUS

Catch-up Phenomenon: Insights from Pathology

Review Article Optical Coherence Tomography Imaging in Acute Coronary Syndromes

Bifurcation stenting with BVS

CLINICAL APPLICATIONS OF OPTICAL COHERENCE TOMOGRAPHY. Konstantina P. Bouki, FESC 2 nd Department of Cardiology General Hospital Of Nikea, Pireaus

Pathology of Vulnerable Plaque Angioplasty Summit 2005 TCT Asia Pacific, Seoul, April 28-30, 2005

Neointimal coverage of bare-metal and sirolimuseluting stents evaluated with optical coherence tomography

Imaging Overview for Vulnerable Plaque: Data from IVUS Trial and An Introduction to VH-IVUS Imgaging

Left main coronary artery (LMCA): The proximal segment

Imaging Atheroma The quest for the Vulnerable Plaque

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque

What is the Optimal Triple Anti-platelet Therapy Duration in Patients with Acute Myocardial Infarction Undergoing Drug-eluting Stents Implantation?

Biodegradable Stents An update and work-in

Clinical Application of OCT in Stent Evaluation

Post PCI functional testing and imaging: case based lessons from FFR React

Cardiovascular Research Foundation and Columbia University Medical Center, New York.

Percutaneous Intervention of Unprotected Left Main Disease

Bifurcation Stenting: IVUS and OCT Information

PCI for Long Coronary Lesion

A Novel Low Pressure Self Expanding Nitinol Coronary Stent (vprotect): Device Design and FIH Experience

The PROSPECT Trial. A Natural History Study of Atherosclerosis Using Multimodality Intracoronary Imaging to Prospectively Identify Vulnerable Plaque

1st Department of Cardiology, University of Athens, Hippokration Hospital, Athens, Greece

Analysis of neointimal coverage after silolimus-eluting stent implantation using optical coherence tomography.

CPIS So-Yeon Choi, MD., PhD. Department of Cardiology Ajou University School of MedicineSuwon, Korea

Acta Cardiol Sin 2018;34: doi: /ACS _34(2) A

eluting Stents The SPIRIT Trials

Clinical Value of OCT. Guidance for Coronary Stenting. Giulio Guagliumi, MD

Quinn Capers, IV, MD

Division of Cardiovascular Medicine, Jichi Medical University Saitama Medical Center, Japan

Cottrell Memorial Lecture. Has Reversing Atherosclerosis Become the New Gold Standard in the Treatment of Cardiovascular Disease?

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

Drug Eluting Stent DES Pathology Update What we know, what we do not know

Yukio Ozaki, M Okumura, TF Ismail 2, S Motoyama, H. Naruse, K. Hattori, H. Kawai, M. Sarai, J. Ishii, Jagat Narula 3

Final Clinical and Angiographic Results From a Nationwide Registry of FIREBIRD Sirolimus- Eluting Stent: Firebird In China (FIC) Registry (PI R. Gao)

Abstract Background: Methods: Results: Conclusions:

2010 Korean Society of Cardiology Spring Scientific Session Korea Japan Joint Symposium. Seoul National University Hospital Cardiovascular Center

Coronary Artery Thermography

Sirolimus Nanocrystal Balloon Based Delivery for Coronary DES ISR

Vulnerable Plaque Pathophysiology, Detection, and Intervention. VP: A Local Problem or Systemic Disease. Erling Falk, Denmark

Αγγειοπλαστική σε Eπαναστενωτικές Bλάβες

GIANT CORONARY ARTERY ANEURYSM FOLLOWING SIROLIMUS-ELUTING STENT IMPLANTATION. D S Gambhir MD, DM, FAMS. FACC

IVUS vs FFR Debate: IVUS-Guided PCI

Goal: Optimal Stent Deployment

Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial

Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents

Assessment of Culprit Lesion Morphology in Acute Myocardial Infarction

Gary S. Mintz,, MD. IVUS Observations in Acute (vs Chronic) Coronary Artery Disease: Structure vs Function

Integrated Use of IVUS and FFR for LM Stenting

Invasive Coronary Imaging Modalities for Vulnerable Plaque Detection

NCVD-PCI Registry. Percutaneous Coronary Intervention (PCI) Registry, MALAYSIA c/o National Heart Association of Malaysia

Formation of and countermeasures for subacute coronary stent thrombosis in elderly diabetic patients

A Polymer-Free Dual Drug-Eluting Stent in Patients with Coronary Artery Disease: Randomized Trial Versus Polymer-Based DES.

in an Unyielding Patient Dr Jason See, Dr Goh Yew Seong, Dr Rohit Khurana Changi General Hospital Singapore

as a Mechanism of Stent Failure

Κλινική Χρήση IVUS και OCT PERIKLIS A. DAVLOUROS ASSOCIATE PROFESSOR OF CARDIOLOGY INVASIVE CARDIOLOGY & CONGENITAL HEART DISEASE

Optical Coherence Tomography

DID OCT change our experience on coronary arteries?

DEB experience in Gachon Universtiy Gil Hospital (in ISR) Soon Yong Suh MD., PhD. Heart Center Gachon University Gil Hospital Seoul, Korea.

대한심장학회춘계학술대회 Satellite Symposium

Subclinical hypothyroidism is associated with lipid-rich plaques in patients with coronary artery disease as assessed by optical coherence tomography

EBC London 2013 Provisional SB stenting strategy with kissing balloon with Absorb

PCI for In-Stent Restenosis. CardioVascular Research Foundation

Dr Aniket Puri. OCT guided BVS for LMCA to LAD : Optimising the 'Pot'

OCT guidance for distal LM lesions

Stents selection and optimal implantation: sizes, design, deployment Abbott Vascular. All rights reserved.

JACC: CARDIOVASCULAR INTERVENTIONS VOL. 2, NO. 5, PUBLISHED BY ELSEVIER INC. DOI: /j.jcin

Evaluation of stent placement and outcomes with optical coherence tomography

Review Article Pathologic Etiologies of Late and Very Late Stent Thrombosis following First-Generation Drug-Eluting Stent Placement

Vessel healings after stenting with different polymers in STEMI patients

Between Coronary Angiography and Fractional Flow Reserve

2yrs 2-6yrs >6yrs BMS 0% 22% 42% DES 29% 41% Nakazawa et al. J Am Coll Cardiol 2011;57:

IVUS Analysis. Myeong-Ki. Hong, MD, PhD. Cardiac Center, Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea

Drug Eluting Stents Sometimes Fail ESC Stockholm 29 Set 2010 Stent Thrombosis Alaide Chieffo

Intracoronary Optical Diagnostics

APPENDIX F: CASE REPORT FORM

Plaque Characteristics in Coronary Artery Disease. Chourmouzios Arampatzis MD, PhD, FESC

Very late thrombosis of sirolimus-eluting stent due to late malapposition: Serial observations with optical coherence tomography

Mid-term results from real-world REPARA registry. Felipe Hernandez, on behalf of the REPARA investigators

OCT GUIDED TREATMENT OF CALCIFIED LESIONS RICHARD SHLOFMITZ, MD CHAIRMAN OF DEPT. OF CARDIOLOGY ST. FRANCIS HOSPITAL ROSLYN, NEW YORK

September Peter Barlis. Royal Brompton Hospital, London, UK

Affiliation/Financial Relationship

Next Generation Drug- eluting Stent : Will It Solve the Problem?

Management of Non-protected Left-Main Bifurcation without Drug Eluting Stent. Masahiko Ochiai MD, FACC, FESC, FSCAI

Periprocedural Myocardial Infarction and Clinical Outcome In Bifurcation Lesion

Bifurcations Bad Krozingen I

The Japanese Pharmacokinetic (PK) Study of Sirolimus-Coated Bx VELOCITY Balloon-Expandable Stent in Patients With de novo Coronary Artery Lesions

Carotid Intravascular Imaging Technique and Indication

Optical Coherence Tomography (OCT): A New Imaging Tool During Carotid Artery Stenting

Prevention of Coronary Stent Thrombosis and Restenosis

Transcription:

Usefulness of OCT during coronary intervention Takashi Akasaka, M.D. Department of Cardiovascular Medicine Wakayama, Japan

Predictors at 12 Months of Stent Thrombosis and Target Lesion Revascularization by Multiple Variable Regression Analysis Variable HR (95% CI) P Stent thrombosis Insulin-dependent diabetes 2.76 (1.71, 4.29) <0.0001 Acute coronary syndrome 1.75 (1.13, 2.67) 0.0105 Age (10-year increment) 1.25 (1.05, 1.50) 0.0122 TLR Acute coronary syndrome 2.46 (1.68, 3.53) <0.0001 Diabetes 1.45 (1.02, 2.04) 0.03 Urban et al, One-Year Follow-Up of the e-cypher Registry. Circulation 113:1434-1441, 2006

Assessment of vascular responses following coronary stenting by OCT between ACS and stable AP.

Subjects and Methods Study population Unstable angina pectoris (UAP; n=22) Stable angina pectoris (SAP; n=17) Antiplatelet and anticoagulation therapy Oral aspirin (100 mg) and ticlopidine (200mg) Intravenous heparin (10,000 U/d for 48hrs in UAP) Coronary intervention Sirolimus-eluting stent OCT image Acquisition a 0.016-inch OCT catheter (ImageWire ; LightLab Imaging, Westford, MA, USA)

Stent profiles and OCT findings in UAP and SAP UAP (n=22) SAP (n=17) p SES diameter, mm 3.1±0.4 3.0±0.8 0.61 SES length, mm 21±4.8 22±4.3 0.50 Max. inflation pressure, atm 19±2.1 19±1.9 0.99 Postdilatation, n (%) 12 (55) 10 (59) 0.79 OCT minimum lumen site minimum stent area, mm 2 6.7±1.7 6.6±1.9 0.86 stent eccentricity 0.86±0.05 0.84±0.07 0.13

ACS; 69 y.o. M #6 Cypher 3.5 x 18 mm Pre PCI Post PCI

ACS; 69 y.o. M #6 Cypher 3.5 x 18 mm

Inadequate stent findings

Stent malapposition Tissue protrusion 1mm Inconsistent strut distribution 1mm Stent edge dissection 1mm 1mm

Inadequate stent findings in UAP and SAP 100 (%) P=0.03 P<0.001 80 P=0.76 60 40 P=0.89 20 0 UAP SAP Stent edge dissection UAP SAP Inconsistent strut distribution UAP SAP Stent malapposition UAP SAP Tissue protrusion

Three vessel OCT examinations in a patient with posterior AMI 1 8 7 8 1 2 34 2 5 6 7 3 4 5 6 The culprit lesion was LCX (#11), and TCFA (1), plaque rupture (2,3) and intracoronary thrombus (2, 3, 4) were observed by OCT. Although the plaques in LAD (7, 8) were not observed, plaque rupture (5, 6) were detected by OCT in the non-culprit lesions of LCX (#13).

Three vessel OCT examinations in a patient with posterior AMI 9 10 9 10 11 1213 11 12 13 Also OCT revealed TCFA (9-13) and plaque rupture( 11,12,13) in the non-culprit lesions of RCA.

OCT analysis of the non-culprit plaques Non-culprit plaque AMI (n=43) SAP (n=25) p-value Plaque rupture (n, %) Plaque erosion (n, %) Intracoronary thrombus (n, %) Fibrous cap thickness (μm) Lipid arc > 90 (n, %) TCFA (n, %) 10 (24) 1 (2) 11(26) 109±55.5 18 (42) 15(35) 1 (4) 0 (0) 0 (0) 194±81.9 12 (48) 2 (8) 0.035 0.632 0.006 <0.001 0.623 0.012

Vascular responses following coronary intervention in patients with stable AP assessed by OCT.

Pre PCI CAG Post PCI

CAG before PCI

CAG after PCI

IVUS Pre PCI Post PCI

OCT Pre PCI Post PCI

Directionary coronary atherctomy : DCA

Directionary coronary atherctomy : DCA pre DCA post DCA

OCT findings Eberhard Grube, MD, Siegburg Heart Center

OCT assessment of non-culprit lesion Case. 47year-old male administrated statin. Baseline T.Chol. 200 mg/dl TG 79 mg/dl HDL-C 47 md/dl LDL-C 128 mg/dl

OCT assessment of non-culprit lesion Case. 47year-old male administrated statin. 9 month later T.Chol. 187 mg/dl TG HDL-C LDL-C 133 mg/dl 49 md/dl 98 mg/dl

OCT assessment of non-culprit lesion (47y.o. male) Baseline 9 month later T.Chol. 200 mg/dl TG 79 mg/dl HDL-C 47 mg/dl LDL-C 128 mg/dl T.Chol. 187 mg/dl TG 133 mg/dl HDL-C 49 mg/dl LDL-C 98 mg/dl Lumen Area 6.1 mm 2 EEL Area 12.3 mm 2 Plaque Area 6.2 mm 2 %plaque burden 50% FI Green Area 2.1 mm 2 68% FF Light green Area 0.4 mm 2 12% DC White Area 0.1 mm 2 2% NC Red area 0.6 mm 2 18% 8.0 mm 2 14.4 mm 2 6.4 mm 2 44% 2.5 mm 2 84% 0.3 mm 2 9% 0.1 mm 2 3% 0.1 mm 2 4%

Changes of plaque characteristics by statin Baseline Follow-up p Statin group Fibrous cap thickness (μm) 114±83 162±75 <0.01 Lipid arc (degrees) 132±37 116±23 <0.01 Non-statin group Fibrous cap thickness (μm) 117±78 129±54 ns Lipid arc (degrees) 129±37 128±28 ns

Conclusions OCT may allow us to identify vulnerable plaques before PCI by demonstrating the lipid-rich plaques, thin fibrous cap, rupture (or ulceration) of the fibrous cap, thrombus and macrophage accumulation. OCT can estimate the results of PCIs precisely, including mal-appositions, thin neo-intima formation, thrombus after DES. OCT can assess the pathophysiology of coronary artery atheroscrelosis in detail.